Published in Am J Pathol on August 01, 2002
Goblet cell carcinoid of the appendix. World J Surg Oncol (2005) 1.87
Embryonic frog epidermis: a model for the study of cell-cell interactions in the development of mucociliary disease. Dis Model Mech (2010) 1.15
Primary signet ring cell carcinoma of the appendix: a rare case report and our 18-year experience. World J Gastroenterol (2008) 1.11
Pseudomyxoma peritonei--a revisit: report of 2 cases and literature review. World J Surg Oncol (2006) 1.00
Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Ann Surg Oncol (2008) 0.97
Pseudomyxoma peritonei: unusual origin from an ovarian mature cystic teratoma. J Clin Pathol (2005) 0.92
High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei. Virchows Arch (2005) 0.92
A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei. Orphanet J Rare Dis (2013) 0.90
Pseudomyxoma peritonei presenting as inguinal hernia. Ulster Med J (2009) 0.86
Immunohistochemical and biochemical characterization of mucin in pseudomyxoma peritonei: a case study. Case Rep Gastroenterol (2011) 0.82
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines. Oncotarget (2015) 0.81
Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects. Orphanet J Rare Dis (2014) 0.80
Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei. Indian J Surg Oncol (2016) 0.80
Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies. World J Gastrointest Surg (2016) 0.79
Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei. Ann Surg Oncol (2012) 0.77
Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals. Surg Today (2011) 0.76
[Morphology of secondary ovarian tumors and metastases]. Pathologe (2014) 0.75
Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment. Cancer Med (2016) 0.75
[Association pregnancy and pseudomyxoma peritonei secondary to mucinous borderline tumor of the ovary: about a case and review of the literature]. Pan Afr Med J (2012) 0.75
[Peritoneal pseudomyxoma arising from an ovarian teratoma associated with Bordeline mucinous tumor: report of a case and review of the literature]. Pan Afr Med J (2013) 0.75
Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases. Glycoconj J (2015) 0.75
Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies. PLoS One (2017) 0.75
Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res (1985) 21.05
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol (1995) 4.33
Epithelial mucin genes. Annu Rev Physiol (1995) 4.29
Diversity of mucin genes, structure, function, and expression. Gastroenterology (1995) 3.97
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol (1999) 2.34
Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci U S A (1997) 2.24
Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg (2000) 2.08
Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99
Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol (1993) 1.94
Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol (1991) 1.86
Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol (2000) 1.72
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol (2001) 1.71
Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology (1994) 1.56
Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol (1998) 1.54
Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treat Res (1996) 1.47
Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg (1994) 1.35
Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression. Hum Pathol (1997) 1.20
Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol (1996) 1.18
Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol (1996) 1.17
Mucoceles of the appendix and peritoneal pseudomyxoma. AMA Arch Pathol (1955) 1.15
A rapid procedure for isolation of RNA-free genomic DNA from mammalian cells. Biotechniques (1993) 1.14
Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation. Mod Pathol (2001) 1.09
Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer? Front Biosci (2001) 1.09
Mucin genes: structure, expression and regulation. Glycoconj J (1994) 1.03
Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. Mod Pathol (1995) 1.01
Unusual tumors of the appendix and pseudomyxoma peritonei. Semin Diagn Pathol (1996) 0.95
Concomitant mucinous tumors of appendix and ovary. Result of a neoplastic field change? Cancer (1992) 0.95
Differential expression of the chromosome 11 mucin genes in colorectal cancer. J Pathol (2001) 0.94
Biochemical identification of the mucus of pseudomyxoma peritonei as the basis for mucolytic treatment. Am J Obstet Gynecol (1986) 0.90
Clinical determinants of treatment failure in patients with pseudomyxoma peritonei. Cancer Treat Res (1996) 0.89
CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging (2001) 0.87
Pseudomyxoma peritonei. Arch Surg (1970) 0.86
Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients. Mod Pathol (2001) 0.86
Pseudomyxoma peritonei. Br J Surg (1999) 0.85
Pseudomyxoma peritonei. Histologic predictors of patient survival. Arch Pathol Lab Med (1994) 0.80
[Pseudomyxoma extraperitonei. Report of 3 cases]. Ann Pathol (1998) 0.79
Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances. Acta Pathol Microbiol Scand A (1978) 0.78
In support of findings on Pseudomyxoma peritonei. Am J Pathol (1999) 0.78
Pedunculated peritoneal surface polyps in pseudomyxoma peritonei syndrome. Histopathology (2001) 0.78
Pseudomyxoma peritonei. Cancer Control (1995) 0.78
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res (2009) 4.47
Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature (2009) 4.21
Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin (2010) 2.45
Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol (2008) 2.20
Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg (2008) 1.90
Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol (2008) 1.82
Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol (2010) 1.82
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun (2008) 1.71
Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer (2007) 1.63
Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg (2011) 1.59
By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol (2003) 1.54
The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol (2008) 1.49
Paint-only is equivalent to scrub-and-paint in preoperative preparation of abdominal surgery sites. J Am Coll Surg (2005) 1.45
Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg (2007) 1.44
Are 12 nodes needed to accurately stage T1 and T2 colon cancers? Dig Dis Sci (2008) 1.44
Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol (2005) 1.41
Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg (2007) 1.41
Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol (2005) 1.37
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol Cancer Ther (2009) 1.36
Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One (2007) 1.36
Survival after resection of ampullary carcinoma: a national population-based study. Ann Surg Oncol (2008) 1.32
Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest (2006) 1.30
Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol (2010) 1.24
Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Oncogene (2002) 1.18
Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis. PLoS One (2010) 1.17
Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One (2008) 1.14
The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget (2013) 1.13
Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16. Am J Transl Res (2010) 1.13
Anatomy of the nipple and breast ducts revisited. Cancer (2004) 1.10
Quality of care in advanced ovarian cancer: the importance of provider specialty. Gynecol Oncol (2010) 1.09
Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. Am J Pathol (2002) 1.08
Incidence and management of abdominal sacrocolpopexy mesh erosions. Am J Obstet Gynecol (2005) 1.07
Anti-CA19-9 diabody as a PET imaging probe for pancreas cancer. J Surg Res (2011) 1.06
Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg (2014) 1.06
MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol (2002) 1.05
Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer. Neoplasia (2009) 1.05
Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg (2008) 1.05
KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res (2011) 1.04
Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology (2009) 1.04
ERalpha suppresses slug expression directly by transcriptional repression. Biochem J (2008) 1.03
Patient satisfaction: an increasingly important measure of quality. Ann Surg Oncol (2006) 1.02
Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol (2007) 1.00
Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer (2010) 1.00
Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer. Cytometry A (2007) 0.99
High complication rate identified in sacrocolpopexy patients attributed to silicone mesh. Urology (2005) 0.98
Imaging and analysis of 3D tumor spheroids enriched for a cancer stem cell phenotype. J Biomol Screen (2010) 0.96
Identification of a novel endothelial-derived gene EG-1. Biochem Biophys Res Commun (2002) 0.96
Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment. EJNMMI Res (2011) 0.94
Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg (2007) 0.93
Presence of anaplastic lymphoma kinase in inflammatory breast cancer. Springerplus (2013) 0.92
Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death. Mol Cancer Res (2009) 0.91
Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg (2014) 0.91
Trends, patterns, and outcomes in the management of malignant colonic polyps in the general population of the United States. Cancer (2010) 0.91
Novel interactions of vitamin E and estrogen in breast cancer. Nutr Cancer (2005) 0.91
The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol (2003) 0.90
An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors. Mol Imaging Biol (2012) 0.90
Utilization of parenteral nutrition following pancreaticoduodenectomy: is routine jejunostomy tube placement warranted? Dig Dis Sci (2008) 0.89
Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. Hum Gene Ther (2002) 0.89
CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer. Int J Mol Imaging (2011) 0.89
Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. Ann Surg Oncol (2013) 0.88
Cystic neoplasms of the pancreas: results of 114 cases. Pancreas (2010) 0.87
A cluster of inflammatory breast cancer (IBC) in an office setting: additional evidence of the importance of environmental factors in IBC etiology. Oncol Rep (2010) 0.87
Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Oncotarget (2010) 0.87
Unexpected readmissions after major cancer surgery: an evaluation of readmissions as a quality-of-care indicator. Surg Oncol Clin N Am (2012) 0.86
An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles. J Surg Res (2013) 0.85
E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Anticancer Res (2010) 0.84
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma. Target Oncol (2013) 0.83
Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice. PLoS One (2009) 0.83
Comorbidities play a larger role in predicting health-related quality of life compared to having an ostomy. Am J Surg (2007) 0.83
Quality of care in surgical oncology. Cancer Control (2009) 0.81
Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival. J Gastrointest Surg (2013) 0.81
A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts. Mol Imaging Biol (2014) 0.80
Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage? Surgery (2013) 0.79
Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Breast J (2003) 0.79
Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma. Cancer (2008) 0.79
Metabolic exploitation of the sialic acid biosynthetic pathway to generate site-specifically labeled antibodies. Glycobiology (2013) 0.77
A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation. Cancer Prev Res (Phila) (2010) 0.77
Angiosarcoma developing in a breast after conservation treatment for breast cancer. Am J Clin Oncol (2003) 0.76
Singular v dual inhibition of SNF2L and its isoform, SNF2LT, have similar effects on DNA damage but opposite effects on the DNA damage response, cancer cell growth arrest and apoptosis. Oncotarget (2012) 0.76
Molecular Imaging Probe Development using Microfluidics. Curr Org Synth (2011) 0.76
Mesenteric rheumatoid nodules masquerading as an intra-abdominal malignancy: a case report and review of the literature. World J Surg Oncol (2009) 0.75
Establishment of an immortalized cell line and transplantable xenograft from a bronchioloalveolar lung carcinoma of a cat. Am J Vet Res (2002) 0.75
Comparative oncological studies of feline bronchioloalveolar lung carcinoma, its derived cell line and xenograft. Cancer Res (2002) 0.75
Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7. Mol Cancer Res (2012) 0.75
Atypical ductal hyperplasia presenting as pseudomicrocalcifications. Breast J (2003) 0.75
Circulating Tumor Cells in Gastrointestinal Cancer: Current Practices and Future Directions. Cancer Treat Res (1) 0.75